Indian drugmaker seeks to toss 'bloated' billion-dollar lawsuit over Covid vaccine candidate
A drug manufacturer is looking to end a suit brought on by a Seattle-based biotech.
Emcure Pharmaceuticals, a Pune, India-based manufacturer of generic drugs, is pressing a court in Washington to toss out a suit brought on by HDT Bio over a vaccine to prevent Covid-19.
The current motion filed by Emcure on Friday seeks to dismiss the case on several grounds, partially because the court has no authority over an Indian company, Emcure says, and because there is no way that Emcure could damage HDT.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.